"የዛሬው ምክረ ሀሳብ የጆንሰን እና ጆንሰን ኮቪድ-19 ክትባት መጀመሪያ ላይ የትኛውም ክትባት ቢወስዱ በዩኤስ ውስጥ ላሉ ብቁ ግለሰቦች እንደ ማበረታቻ መጠቀምን ይደግፋል" ሲሉ ፖል ስቶፍልስ፣ የስራ አስፈፃሚ ኮሚቴ ምክትል ሊቀመንበር እና ዋና የሳይንስ ኦፊሰር ጆንሰን እና ጆንሰን.
"Today's recommendation supports the use of the Johnson & Johnson COVID-19 vaccine as a booster for eligible individuals in the U.S. regardless of which vaccine they initially receive," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson.